Susquehanna International Group’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-289
| Closed | -$3.28K | – | 7067 |
|
|
2022
Q4 | $3.28K | Buy |
+289
| New | +$3.28K | ﹤0.01% | 5599 |
|
|
2022
Q3 | – | Sell |
-371
| Closed | -$22K | – | 7228 |
|
|
2022
Q2 | $22K | Buy |
371
+337
| +991% | +$20K | ﹤0.01% | 5406 |
|
|
2022
Q1 | $14K | Sell |
34
-17
| -33% | -$7K | ﹤0.01% | 5523 |
|
|
2021
Q4 | $50K | Buy |
51
+5
| +11% | +$4.9K | ﹤0.01% | 5466 |
|
|
2021
Q3 | $89K | Sell |
46
-56
| -55% | -$108K | ﹤0.01% | 5002 |
|
|
2021
Q2 | $272K | Buy |
102
+29
| +40% | +$77.3K | ﹤0.01% | 4563 |
|
|
2021
Q1 | $303K | Sell |
73
-33
| -31% | -$137K | ﹤0.01% | 4354 |
|
|
2020
Q4 | $609K | Buy |
106
+18
| +20% | +$103K | ﹤0.01% | 3187 |
|
|
2020
Q3 | $537K | Sell |
88
-42
| -32% | -$256K | ﹤0.01% | 2932 |
|
|
2020
Q2 | $725K | Sell |
130
-201
| -61% | -$1.12M | ﹤0.01% | 2516 |
|
|
2020
Q1 | $1.23M | Buy |
331
+250
| +309% | +$930K | ﹤0.01% | 1777 |
|
|
2019
Q4 | $405K | Buy |
81
+54
| +200% | +$270K | ﹤0.01% | 2869 |
|
|
2019
Q3 | $63K | Buy |
+27
| New | +$63K | ﹤0.01% | 4167 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5177 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4876 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5158 |
|
|
2018
Q3 | – | Sell |
-8
| Closed | -$8K | – | 5018 |
|
|
2018
Q2 | $8K | Sell |
8
-38
| -83% | -$38K | ﹤0.01% | 3538 |
|
|
2018
Q1 | $235K | Buy |
+46
| New | +$235K | ﹤0.01% | 2716 |
|
|
2017
Q4 | – | Sell |
-8
| Closed | -$68K | – | 4722 |
|
|
2017
Q3 | $68K | Sell |
8
-19
| -70% | -$162K | ﹤0.01% | 2934 |
|
|
2017
Q2 | $205K | Buy |
+27
| New | +$205K | ﹤0.01% | 3049 |
|
|
2017
Q1 | – | Sell |
-11
| Closed | -$121K | – | 4659 |
|
|
2016
Q4 | $121K | Buy |
+11
| New | +$121K | ﹤0.01% | 3859 |
|